Related Experiment Videos
The prodigiosins, proapoptotic drugs with anticancer properties
Ricardo Pérez-Tomás1, Beatriz Montaner, Esther Llagostera
1Cancer Cell Biology Research Group, Departament de Biologia Cel.lular i Anatomia Patològica, Universitat de Barcelona. Feixa Llarga s/n. E-08907 L'Hospitalet, Barcelona, Spain. rperez@bell.ub.es
Biochemical Pharmacology
|October 14, 2003
Summary
Prodigiosins (PGs), natural red pigments from bacteria, show promising anticancer activity. Research is exploring their mechanisms and molecular targets for drug development.
Area of Science:
- Microbiology
- Pharmacology
- Biochemistry
Background:
- Prodigiosins (PGs) are bacterial pigments with a pyrrolylpyrromethene core.
- Some PGs exhibit immunosuppressive and apoptotic effects in vitro, and antitumour activity in vivo.
- Identifying the cellular targets of PGs is crucial for their therapeutic development.
Purpose of the Study:
- To review the pharmacological activities of prodigiosins and related compounds.
- To discuss proposed mechanisms of action, including pH modulation, cell cycle inhibition, DNA cleavage, and kinase regulation.
- To highlight novel synthetic prodigiosin derivatives with reduced toxicity.
Main Methods:
- Literature review of existing studies on prodigiosins.
- Analysis of pharmacological data and in vitro/in vivo studies.
- Discussion of proposed molecular targets and mechanisms.
Main Results:
- Prodigiosins demonstrate significant antitumour potential.
- Several mechanisms of action are proposed, indicating diverse biological effects.
- Synthetic derivatives offer improved safety profiles.
Conclusions:
- Prodigiosins represent a promising new class of anticancer agents.
- Further research into their molecular targets will facilitate drug development.
- These compounds hold considerable promise for the pharmaceutical industry.